	Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial. Nat Commun Sharma P, Krainer M, Saad F, Castellano D, Bedke J, Kwiatkowski M, Patnaik A, Procopio G, Wiechno P, Kochuparambil S, Thomas C, Arranz Arija JÁ, McCune SL, Hansen S, Daugaard G, Delgado Mingorance JI, Kukard C, Subudhi SK, Basu S, Jindal S, Siddiqui BA, Lako A, Gupta S, Fedorov V, Amin NP, Campos A, Wang Y, David JM, Pachynski RK. PMID: 42098105 [PubMed - as supplied by publisher]
	Druggable Genome-Wide Mendelian Randomization Identifies Therapeutic Targets and DNA Methylation-Mediated Regulation in Urological Malignancies. Technol Cancer Res Treat Li T, Wei Q. PMID: 42098041 [PubMed - indexed for MEDLINE]
	Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial. BMJ Open Cooper S, Alexander S, Breitkreutz D, Casey F, Christodouleas J, Dassen MG, Dell'acqua V, Dunlop A, Herbert T, Kolias P, Mitchell A, Pos FJ, Westley R, Tree AC, Van Der Heide UA, Vesprini D. PMID: 42097645 [PubMed - indexed for MEDLINE]
	Outdoor air pollution and prostate cancer risk in the NIH-AARP diet and health study. J Natl Cancer Inst Post LM, Hurwitz L, Fisher JA, Kaufman JD, Koutros S, Jones RR. PMID: 42097289 [PubMed - as supplied by publisher]
	Optimizing Care for Patients With Metastatic Castration-Resistant Prostate Cancer. Am Soc Clin Oncol Educ Book Cren PY, Buteau J, Fatema U, Patel R, Saraiya B, Emmett L, Fizazi K. PMID: 42096668 [PubMed - indexed for MEDLINE]
	Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men With Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE). J Clin Oncol McKay RR, Xie W, Ajmera A, Araneta A, Jamieson C, Folefac E, Hussain A, Kyriakopoulos CE, Manning DK, Olson A, Parikh M, Parikh R, Saraiya B, Pasquina LW, Madison R, Clifford S, Childress M, Gasco A, Ivy P, Van Allen E, Kochupurakkal B, Shapiro GI. PMID: 42096662 [PubMed - as supplied by publisher]
	Autoencoder/RandomForest-TabPFN for Cross-Cancer Metabolomics: Prostate and Breast Cancer Diagnosis Using Paper Spray and Ion Mobility-Mass Spectrometry Techniques. Gigascience Hauns S, Pinto FG, Khyriem C, Singh A, Al-Sadi A, Yazeedi TA, Mohammad R, Cisse B, Garrett TJ, Uddin M, Soares NC, Backofen R, Alkhnbashi OS. PMID: 42096511 [PubMed - as supplied by publisher]
	[Solitary fibrous tumor of the prostate mimicking a tumor of the vesicoprostatic junction. Case report]. Rev Med Inst Mex Seguro Soc Díaz-Fuentes H, Zapot-Martínez JC, Cabrera-Mora NA, Ramos-Arceo E, Tavares-García JS. PMID: 42096255 [PubMed - indexed for MEDLINE]
	[First cohort: Robotic radical prostatectomy at the Mexican Institute for Social Security]. Rev Med Inst Mex Seguro Soc Fuziwara-Ruíz S, Hernández-Toriz N, Huerta-Gómez JC, Quintero-Becerra J, Martínez-Cornelio A, Zapot-Martínez JC, Delgado-Herrera A, Castro-Chávez C, Pérez-Ramírez O. PMID: 42095811 [PubMed - indexed for MEDLINE]
	Urologist and radiologist contributions to variation in prostate cancer detection at fusion biopsy. BJU Int Triner D, Ginsburg KB, Moser A, Labardee C, Korman H, Domina J, Cher ML, Peabody J, Semerjian A, Purysko A, George AK, Borza T, Krumm AE, Michigan Urological Surgery Improvement Collaborative (MUSIC). PMID: 42095733 [PubMed - as supplied by publisher]
	The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma. Clin Cancer Res Pakvisal N, Wongkongkathep P, Bunrasmee W, Sodsai P, Siriluksana J, Boonnak N, Sangcharoen T, Trakarnsanga B, Sukprakun S, Wantanasiri P, Chotirosniramit K, Phanichkrivalkosil M, Nanthawong S, Chanchaem P, Mankhong S, Kumpunya S, Supabphol S, Sirijun N, Kongtragulsub K, Pearngam P, Somparn P, Payne DM, Zhao B, Praphanphoj V, Pornputtapong N, Sriswasdi S, Wichadakul D, Uttamapinan S, Angspatt P, Wongchanapat P, Teeyapun N, Luangdilok S, Sitthideatphaiboon P, Susiriwatananont T, Zungsontiporn N, Parinyanitikul N, Tanasanvimon S, Vinayanuwattikun C, Salazar A, Hirankarn N, Sriuranpong V, Pisitkun T. PMID: 42095629 [PubMed - as supplied by publisher]
	Impact of European Association of Urology Combination and Platinum Eligibility on Real-World Treatment Sequences and Survival in Japanese Patients With Metastatic Urothelial Carcinoma. Int J Urol Kawahara T, Nagumo Y, Tanuma K, Hamada K, Yamaguchi A, Nitta S, Shiga M, Ikeda A, Hoshi A, Kandori S, Nishiyama H. PMID: 42095391 [PubMed - indexed for MEDLINE]
	Future opportunities and nuances with the use of PSMA PET in prostate cancer (MD PET 1). Theranostics Morgans AK, Pieczonka CM, Yu EYW, Nagar H, Gomella LG, Osman MM, Koo PJ, Finkelstein SE. PMID: 42094603 [PubMed - indexed for MEDLINE]
	The diagnostic value of mpMRI and PSMA-targeted PET/CT in radiorecurrent prostate cancer: a narrative review. Front Oncol Merani U, Venturi A, Calleris G, Dematteis A, Iorio GC, Marquis A, Sasia A, Marra G, Gontero P, Oderda M. PMID: 42094204 [PubMed]
	Androgen Deprivation Therapy (ADT) and Radiotherapy (RT) with Imaging Evaluation Longitudinally (ARIEL) trial: protocol, early results, and implications of neoadjuvant ADT for focal RT boost in prostate cancer. medRxiv Song Y, Rojo Domingo M, Nguyen L, Conlin CC, Dhillon N, Do S, Dornisch A, Hahn ME, Karunamuni R, Kim J, Lee KL, Liu J, McKay RR, Mell LK, Mundt AJ, Patel R, Qiao EM, Rose B, Rupareliya R, Schaub H, Schwartzman A, Stewart T, Dale AM, Seibert TM. PMID: 42094159 [PubMed]
	Testicular cancer incidence and associations with prior epididymo-orchitis or urinary tract infections: a national cohort study in Sweden, 1964-2018. BMJ Oncol Jansåker F, Li X, Sundquist K. PMID: 42094024 [PubMed]
	RNA methylation in urological cancers: regulatory logic, biological functions, and clinical relevance. Front Immunol Peng J, Xie C, Xie Z, Tang F, Wang Z, Liu M, Yu L, Tang C, Liu Z, Yuan Z, Liao L, Zou X, Liu X, Yi M, Tao H, Wei W, Liu T, Liao Y. PMID: 42093977 [PubMed - indexed for MEDLINE]
	Modifiable risk factors of prostate cancer: Insights from a hospital-based study. Oncoscience Kulshekar M, Patil AB, Nerli RB. PMID: 42093920 [PubMed]
	External beam focal boost radiotherapy to intraprostatic lesions in prostate cancer: a scoping review. Phys Imaging Radiat Oncol Liu Y, Qin S, Ren X, Bai Y, Gao X, Li H, Ma M. PMID: 42093677 [PubMed]
	Early Detection of Biochemical Recurrence in Prostate Cancer Patients with PSA Levels â‰¤0.5 ng/mL; Comparison Study between [Â¹â¸F]PSMA-1007 and [â¶â¸Ga]Ga-PSMA-11 PET/CT. World J Mens Health Cho S, Seo HJ, Bang S, Lee S, Cho KS, Lee S, Yun M. PMID: 42093259 [PubMed - as supplied by publisher]

Articles 1 - 20 / 178061

Page 1 of 8904



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy